Back to Agenda
Session 2 / Venue 3: Asia Town Hall
Session Chair(s)
Nobumasa Nakashima
Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan
Japan is the second largest pharmaceutical market in the world and as a member of ICH, Japan plays a primary role in pharmaceutical regulations. In the recent years, the international positioning of Asia has enhanced as the center of development, manufacturer, supplier and market of pharmaceuticals. In addition, most of Asian countries are regarded as “pharma-emerging” countries and their efforts attract attentions from European countries, the US, and industry. In Japan, Abe Cabinet established the “Reconstruction Project” and evaluation on the partial amendment of Pharmaceuticals Affairs Act, and APAC (Asia Partnership Conference of Pharmaceutical Association) has been advocated by the industry. In other Asian countries such as Singapore and Chinese Taipei, proactive regulatory reformation and international cooperation has been proceeding. In this session, representatives from Asian regulatory agencies and industry will explain current situation and trends of each country, and discuss future direction of Asian cooperation.
Speaker(s)
Promoting Medical Innovation “Health and Medical Care Strategy”
Mitsuaki Kamata
Ministry of Health, Labour and Welfare, Japan
Director, Pharmaceutical and Food Safety Bureau
Cooperation in Asia (with focus on APAC) from industry point of view
Yutaka Tsuchiya
Eisai Co., Ltd., Japan
Chairman (Deputy President (Representative Corporate Officer)),
Recent Trend of Pharmaceutical Regulations in Singapore
Christina Lim, PhD
Health Sciences Authority, Singapore
Senior Director, International Relations, Health Product Regulation Group
Recent Trend of Pharmaceutical Regulations in Taiwan
Meir-Chyun Tzou, PhD
Food and Drug Administration, Department of Health, Taiwan
Director, Division of Drugs and New Biotechnology Products
Recent Trend of Pharmaceutical Regulations in Korea
Sun Hee Lee, PhD
Ministry of Food and Drug Safety, Korea, Republic of
Director General of Institute
Have an account?